Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary Oct 27, 2016	Harvard Bioscience Reports Third Quarter 2016 Financial Results Announces the Disposition of AHN Biotechnologie GmbH for $1.7 million	View HTML Harvard Bioscience Reports Third Quarter 2016 Financial Results 80.2 KB
Toggle Summary Oct 13, 2016	Harvard Bioscience Schedules Third Quarter 2016 Conference Call for October 27 at 4:30 PM ET HOLLISTON, Mass., Oct. 13, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its third quarter 2016 after market trading hours on Thursday, October 27, 2016.	View HTML Harvard Bioscience Schedules Third Quarter 2016 Conference Call for October 27 at 4:30 PM ET 13.5 KB
Toggle Summary Jul 28, 2016	Harvard Bioscience Reports Second Quarter 2016 Financial Results Conference Call To Be Held at 8:30 AM ET Today	View HTML Harvard Bioscience Reports Second Quarter 2016 Financial Results 81.1 KB
Toggle Summary Jul 18, 2016	Harvard Bioscience Schedules Second Quarter 2016 Conference Call for July 28 at 8:30 AM ET HOLLISTON, Mass., July 18, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its second quarter 2016 before market trading hours on Thursday, July 28, 2016.	View HTML Harvard Bioscience Schedules Second Quarter 2016 Conference Call for July 28 at 8:30 AM ET 13.5 KB
Toggle Summary May 31, 2016	Harvard Bioscience to Attend The Benchmark Company, LLC One-on-One Conference in Milwaukee, Wisconsin on June 2, 2016 HOLLISTON, Mass., May 31, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will participate in The Benchmark Company, LLC One-on-One Conference at The Pfister Hotel in Milwaukee,	View HTML Harvard Bioscience to Attend The Benchmark Company, LLC One-on-One Conference in Milwaukee, Wisconsin on June 2, 2016 12.7 KB
Toggle Summary May 12, 2016	Harvard Bioscience Reports First Quarter 2016 Financial Results Conference Call To Be Held at 8:30 AM ET Today	View HTML Harvard Bioscience Reports First Quarter 2016 Financial Results 66.1 KB
Toggle Summary May 4, 2016	Harvard Bioscience Regains Compliance with NASDAQ's Continued Listing Requirements HOLLISTON, Mass., May 04, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, announced today that it received written notification from NASDAQ (the "Notice") stating	View HTML Harvard Bioscience Regains Compliance with NASDAQ's Continued Listing Requirements 12.1 KB
Toggle Summary Apr 29, 2016	Harvard Bioscience Reports Fourth Quarter and Year-End 2015 Results, Preliminary First Quarter 2016 Revenues and 2016 Financial Guidance Reports Results of Embezzlement Investigation Conference Call to Discuss 2015 and First Quarter 2016 Results to be Held on May 12, 2016 at 8:30 AM ET HOLLISTON, Mass., April 29, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and	View HTML Harvard Bioscience Reports Fourth Quarter and Year-End 2015 Results, Preliminary First Quarter 2016 Revenues and 2016 Financial Guidance 70.2 KB
Toggle Summary Mar 28, 2016	Harvard Bioscience Delays Filing of Annual Report on Form 10-K and Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2015 Revenue HOLLISTON, Mass., March 28, 2016 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today announced that the filing of its Annual Report on Form 10-K for the year ended	View HTML Harvard Bioscience Delays Filing of Annual Report on Form 10-K and Announces Preliminary Unaudited Fourth Quarter and Fiscal Year 2015 Revenue 16.3 KB
Toggle Summary Mar 17, 2016	Harvard Bioscience Receives NASDAQ Delinquency Notice HOLLISTON, Mass., March 17, 2016 (GLOBE NEWSWIRE) -- On March 16, 2016, Harvard Bioscience, Inc. (Nasdaq:HBIO) (the "Company"), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, received a notice from NASDAQ (the "Notice") stating the Company is	View HTML Harvard Bioscience Receives NASDAQ Delinquency Notice 15.9 KB